U.S. Other Utilities Stock News

Considering whether Kyndryl Holdings is starting to look like value after a tough run, or if the current price still does not fully reflect the risks. The stock last closed at US$12.85, with returns of 1.6% over 7 days and 0.2% over 30 days, but a much softer picture year to date with a 49.6% decline and a 61.2% decline over 1 year. Recent coverage has focused on Kyndryl Holdings as a standalone IT services player following its separation from IBM. This has highlighted the challenge of...

Tutor Perini (TPC) has recently drawn investor attention after its shares closed at $78.71. The company reported annual revenue of US$5.54b and net income of US$80.44m from its diversified construction operations. See our latest analysis for Tutor Perini. The recent 1-month share price return of 6.99% and 90-day share price return of 17.44% sit against a very large 1-year total shareholder return, suggesting that momentum has been building over both shorter and longer horizons. If Tutor...

IAC/InterActiveCorp, led by Barry Diller, has increased its stake in MGM Resorts International to more than 23%. This move makes IAC the largest shareholder of MGM Resorts International, reinforcing its role in the company’s ownership structure. The development highlights fresh attention on NYSE:MGM and how large shareholders may influence future decisions. MGM Resorts International, trading under NYSE:MGM, last closed at $36.78. The stock shows a 19.6% return over the past year, while...

Shoals Technologies Group recently took part in a Barclays-hosted virtual webinar on battery energy storage systems, where its president and BESS product lead discussed the company’s products, market paths, and competitive positioning for investors and other interested participants. At the same time, Shoals has seen heightened options market activity and implied volatility, suggesting traders are closely watching potential catalysts around its BESS expansion and broader outlook. We’ll now...

Viridian Therapeutics recently reported positive topline results from its Phase 3 REVEAL-1 trial of elegrobart in active thyroid eye disease, showing significant improvements in eye bulging and double vision with subcutaneous dosing and a generally manageable safety profile. Yet the data immediately sparked debate over how elegrobart stacks up against existing thyroid eye disease therapies, putting the focus on differentiation rather than simple success or failure of the trial. Next, we’ll...

AECOM (ACM) has attracted fresh attention after being reselected as prime consultant for San Diego Unified School District’s capital bond programs and securing a position on the U.S. Missile Defense Agency’s large SHIELD contract. See our latest analysis for AECOM. Despite winning fresh work in education and defense, AECOM’s recent share price performance has been softer, with a 30 day share price return of 11.9% and a year to date share price return of 11.1%. Longer term total shareholder...

If you are wondering whether MakeMyTrip at around US$37.88 is a bargain or just looks cheap, the key question is how its current price compares with its underlying worth. The stock has seen sharp moves recently, with a 3.1% decline over the last 7 days, a 32.3% decline over 30 days, and year to date returns of a 53.7% decline, although the 3 year and 5 year returns sit at 61.7% and 26.6% respectively. This price action comes as MakeMyTrip continues to sit in focus as a Nasdaq listed online...

TSMC secured government approval to build 3nm manufacturing capacity at its second chip facility in Japan. The new plant is targeting production in 2028, extending TSMC’s advanced manufacturing footprint beyond Taiwan. This move broadens the company’s global supply base as demand for AI related chips continues to grow. For investors watching Taiwan Semiconductor Manufacturing (NYSE:TSM), this approval adds another piece to the bigger picture around capacity and location. The stock trades at...

UniFirst (UNF) has just laid out a fresh set of numbers, with the latest quarter showing revenue of US$621.3 million and basic EPS of US$1.89, against a backdrop where trailing twelve month revenue sits at about US$2.4 billion and EPS at roughly US$7.58. Over recent quarters the company has seen revenue move from US$602.2 million in Q2 2025 to US$610.8 million in Q3 2025, US$614.4 million in Q4 2025 and US$621.3 million in Q1 2026, while basic EPS has ranged from US$1.32 to US$2.40 over that...

In late March 2026, United Airlines and the Association of Flight Attendants-CWA reached a tentative five-year agreement that would deliver industry-leading pay, new boarding and gap-time compensation, and a US$740 million signing bonus to roughly 30,000 flight attendants, pending union approval and ratification. The deal, which would make United’s flight attendants the best-paid in the sector by the end of the contract, underscores how labor relations and cost structures are evolving at a...

If you are wondering whether CRA International is good value at its recent price of US$164.00, the starting point is understanding how that price lines up with the underlying business. The stock has moved around recently, with a 4.7% gain over the last 7 days, a 9.0% decline over 30 days, year to date returns of an 18.2% decline, and a 6.1% decline over the last year, set against longer term returns of 62.1% over 3 years and 138.3% over 5 years. Recent news coverage has focused on CRA...

Darden Restaurants, Inc. reported past third-quarter fiscal 2026 results with sales of US$3,345.3 million and net income of US$306.8 million, alongside updated full-year guidance, a US$1.50 quarterly dividend, and continued share repurchases. Despite higher quarterly and nine-month sales and ongoing capital returns through dividends and buybacks, the quarter showed slightly lower net income and earnings per share than a year earlier, highlighting the balance between growth and...

In its recent fourth-quarter update, Merchants Bancorp reported revenue, earnings per share, and net interest income above analyst expectations, alongside improved asset quality with criticized and nonperforming loans both reduced. Chairman and CEO Michael F. Petrie also reported that total assets reached a record US$19.40 billion, underscoring management’s confidence in the bank’s growth plans for 2026 and beyond. Next, we’ll examine how Merchants Bancorp’s record asset base and stronger...

Why recent macro headlines matter for Wells Fargo Recent headlines around bank exposure to nonbank financial institutions and Wells Fargo’s (WFC) own adjustment to its S&P 500 outlook have put big bank risk profiles back under the microscope ahead of earnings. See our latest analysis for Wells Fargo. At a share price of US$80.57, Wells Fargo has seen a 1 day share price return of 1.21%, while the 90 day share price return of 13.55% and year to date share price return of 15.37% point to fading...

Speculation has picked up that GameStop could be eyeing Best Buy (NYSE:BBY) for a major acquisition after GameStop management flagged interest in a "very, very, very big" deal. Commentary from GameStop about pursuing efficiency focused acquisitions has put Best Buy back in the spotlight as a potential target. The idea of a tie up between the two specialty retailers is drawing fresh attention to Best Buy's role in consumer electronics and services. Best Buy shares recently closed at $64.31,...

Savara Inc. recently announced that the European Medicines Agency validated its Marketing Authorization Application for MOLBREEVI in autoimmune pulmonary alveolar proteinosis, while the U.S. FDA is reviewing the drug’s Biologics License Application under Priority Review with an August 22, 2026 action date. MOLBREEVI, a recombinant GM-CSF inhalation therapy with multiple expedited and orphan designations, could become the first approved treatment specifically for autoimmune PAP in major...

Renewed attention on Dynatrace (DT) has been driven by reports of strong billings growth, robust customer demand, and improved operating margins, along with renewed interest in high-quality SaaS names as geopolitical tensions appear to ease. See our latest analysis for Dynatrace. Despite the recent enthusiasm around billings and margins, Dynatrace’s 1 year total shareholder return of 23.98% and 5 year total shareholder return of 26.24% show that longer term holders have not been rewarded. A...

Morgan Stanley recently reported quarterly revenue and earnings that surpassed consensus forecasts, while its Wealth Management arm crossed the US$1.00 trillion mark in IRA assets under management. This combination of positive earnings surprises and a larger, fee-based retirement asset pool underlines the growing importance of recurring wealth management revenues in Morgan Stanley’s business mix. We’ll now examine how Morgan Stanley’s stronger earnings and US$1.00 trillion IRA milestone...

Recent share performance and business snapshot Teradata (TDC) has been under pressure recently, with the stock showing negative returns over the past week, month and past 3 months, despite a positive 1 year total return profile. The company reports annual revenue of US$1.66b and net income of US$130.0m, split between Product Sales and Consulting Services across United States and international markets in sectors such as financial services and healthcare. See our latest analysis for...

Elastic (NYSE:ESTC) is back in focus after announcing that Elastic Cloud Hosted has achieved FedRAMP High authorization on AWS GovCloud (US). This authorization opens the door to more sensitive U.S. federal workloads. See our latest analysis for Elastic. Despite the FedRAMP High milestone and recent additions such as Elastic Workflows and inclusion in the NASDAQ Internet Index, Elastic’s share price has faced pressure. The 30 day share price return shows a decline of 5.69%, and the 1 year...

Kohl's (KSS) is back in focus as management outlines supply chain changes aimed at fixing past inventory gaps in smaller stores, while also extending its Sephora partnership with additional beauty brands. See our latest analysis for Kohl's. Despite news on supply chain fixes and the expanding Sephora partnership, the share price has a 30 day return of negative 16.8% and a year to date share price return of negative 39.6%. The 1 year total shareholder return of 55.3% contrasts sharply with...

PVH (PVH) has just wrapped up FY 2026 with fourth quarter revenue of US$2.5 billion and a basic EPS loss of US$3.55, capping a trailing twelve month profile that includes total revenue of US$9.0 billion and basic EPS of US$0.53. Over recent quarters, the company has seen revenue move from US$2.0 billion in Q1 2026 to US$2.5 billion in Q4 2026. Quarterly basic EPS has swung between a loss of US$0.88 and a gain of US$4.66, leaving investors to focus on how thin trailing net margins and that one...

Maui Land & Pineapple Company (MLP) opened FY 2025 with mixed quarterly numbers, reporting Q3 revenue of US$4.5 million and basic EPS of US$0.01, set against a trailing 12 month net loss of US$11.3 million on revenue of US$18.3 million. Over recent quarters, revenue has ranged from US$2.6 million to US$5.8 million per quarter, while basic EPS has moved between a loss of US$0.44 and a small profit of US$0.01 as reported for Q3 2025. For investors, the latest figures keep the spotlight on...

Alumis Inc. recently reported positive Phase 3 ONWARD1 and ONWARD2 results for envudeucitinib in moderate-to-severe plaque psoriasis, showing strong skin clearance, quality-of-life gains, and a generally well-tolerated safety profile, and it now plans to submit a New Drug Application to the U.S. Food and Drug Administration in the second half of 2026. A particularly interesting angle for investors is envudeucitinib’s high rates of scalp psoriasis clearance and rapid itch relief, which could...